European Patent Office

T 0356/22 (Pomalidomide formulations / CELGENE) of 20.12.2024

European Case Law Identifier
ECLI:EP:BA:2024:T035622.20241220
Date of decision
20 December 2024
Case number
T 0356/22
Petition for review of
-
Application number
18160247.5
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on Article 056 EPC
Application title
FORMULATIONS OF 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE
Applicant name
Celgene Corporation
Opponent name
Pruß, Timo
HGF Limited
Generics (UK) Ltd
Hoffmann Eitle
Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
Keywords
Inventive step - (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

The decision under appeal is set aside.

The patent is revoked.